PPHF 2016: PPHF Epidemiology and Laboratory Capacity Program – US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated Hospitalizations – financed in part by 2016 Prevention and Public Health Fu
ArchivedCenters for Disease Control and Prevention - ERA
Description
Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups.Because influenza viruses are constantly changing and vaccines are reformulated every year, annualestimates of the effectiveness of influenza vaccines in preventing influenza infection and itsassociated complications are needed in order to evaluate the protection provided by annual,nationwide vaccination programs.Each year in the United States, influenza viruses infect up to 20%
Who can apply
- Others
Contact
OGS TIMS <br/>770-488-2700
OGSTIMS@cdc.gov
- PostedMay 24, 2016
- ClosesJun 24, 2016
- Award floor$0
- Award ceiling$0
- Program funding$0
- Expected awards5
- CFDA93.733
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro